Key facts
- Notable investors include InnoPinnacle.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Kerui Biopharmaceuticals
- ·The full record, as it builds
Funding rounds
No funding rounds for Kerui Biopharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kerui Biopharmaceuticals
Developer of biomedical products intended for research and experimental advancement. The company offers biochemistry-based product development, technical consulting services, and international trade capabilities, enabling the pharmaceutical and biotechnology market to conduct applied research, accelerate translational studies, integrate cross-border collaboration, manage regulatory compliance, and expand innovation pipelines while reducing operational barriers and supporting diverse applications in therapeutic and diagnostic development.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Kerui Biopharmaceuticals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kerui Biopharmaceuticals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kerui Biopharmaceuticals in its N-PORT filings yet. We sweep new filings monthly.